Adtalem Global Education (NYSE:CVSA) Downgraded to “Hold” Rating by Wall Street Zen

Adtalem Global Education (NYSE:CVSA) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report released on Saturday.

Several other research firms also recently weighed in on CVSA. Barrington Research restated an “outperform” rating and issued a $170.00 price target on shares of Adtalem Global Education in a research note on Monday, June 8th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Adtalem Global Education in a research note on Friday, May 22nd. Finally, Truist Financial boosted their target price on Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, May 11th. Two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $155.00.

Adtalem Global Education Price Performance

NYSE:CVSA opened at $115.58 on Friday. The company has a market capitalization of $3.93 billion, a price-to-earnings ratio of 18.00, a P/E/G ratio of 0.87 and a beta of 0.62. The company has a debt-to-equity ratio of 0.36, a current ratio of 0.70 and a quick ratio of 0.70. Adtalem Global Education has a one year low of $86.97 and a one year high of $156.26. The business’s 50-day simple moving average is $123.80.

Adtalem Global Education (NYSE:CVSA) last announced its earnings results on Thursday, May 7th. The company reported $1.98 earnings per share for the quarter, beating analysts’ consensus estimates of $1.73 by $0.25. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The business had revenue of $487.03 million during the quarter. During the same period in the prior year, the business posted $1.92 EPS. Adtalem Global Education’s revenue for the quarter was up 4.5% on a year-over-year basis. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. On average, equities research analysts expect that Adtalem Global Education will post 8.04 earnings per share for the current fiscal year.

Insider Activity

In other news, SVP Douglas G. Beck sold 9,615 shares of the stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $127.03, for a total transaction of $1,221,393.45. Following the sale, the senior vice president owned 38,159 shares in the company, valued at $4,847,337.77. This represents a 20.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Stephen W. Beard sold 15,874 shares of the firm’s stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $131.25, for a total transaction of $2,083,462.50. Following the sale, the chief executive officer directly owned 429,324 shares of the company’s stock, valued at $56,348,775. This trade represents a 3.57% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 53,183 shares of company stock worth $6,914,570. Corporate insiders own 2.50% of the company’s stock.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.